American Regent

American Regent

Produces sterile injectable medications for healthcare

Overview

American Regent is a pharmaceutical company that develops, manufactures, and supplies sterile injectable medicines for U.S. and Canadian healthcare providers, including brands and generic injectables. Its products are produced in sterile form and used by hospitals, clinics, and other providers to treat patients. The company operates manufacturing sites in New York, Ohio, and Pennsylvania and ships across the United States and Canada, aiming to ensure a steady, broad portfolio of injectable therapies for patients. It differentiates itself through its commitment to reliable supply and through ongoing investments to modernize and expand its U.S. manufacturing capabilities, supporting sustainable growth and the well-being of its employees and customers. Its goal is to maintain a steady supply of high-quality injectable medicines by expanding capacity and improving efficiency to serve the healthcare marketplace.

About American Regent

Simplify's Rating
Why American Regent is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Healthcare

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York

Founded

N/A

People at American Regent

People at American Regent who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The 2024 TPX-100 partnership targets knee osteoarthritis, opening a new therapeutic area
  • FDA-approved Vasopressin Injection launched in 2024 addresses vasodilatory shock for hospitals
  • 2024 Amneal partnership accelerates generic injectable launches supporting broader market access

What critics are saying

  • Amphastar's vasopressin price war captures 60% hospital contracts in 9 months with high impact
  • Exela's atropine sulfate 0.3mL vial erodes $12M annual revenue in pediatric emergency kits
  • Somerset's patent challenge blocks $15M Multrys launch in 2027 and forces $3M litigation costs

What makes American Regent unique

  • American Regent leads IV iron therapy with 25 years of dominance in the market
  • The company acquired HBT Labs in 2024 to expand into oncology and complex injectables
  • It operates a $68M modernized New Albany facility increasing sterile injectable production capacity

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Profit Sharing

Paid Time Off

401(k) Company Match

Recently Posted Jobs

Sign up to get curated job recommendations

American Regent is Hiring for 19 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →